Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06262594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lemborexant Treatment of Insomnia Linked to Epilepsy

Study acronym: L'ÉTOILE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 13, 2025 (before its estimated April 18, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Apr 18, 2025 to Apr 18, 2026
    • Start date: Apr 18, 2024 to Oct 29, 2024
    • Study sites: 1 to 2
    • Study completion date: Apr 18, 2026 to Apr 18, 2027
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Feb 8, 2025 to Apr 18, 2025
    • Study completion date: Feb 8, 2026 to Apr 18, 2026
    • Start date changed from estimate of Feb 8, 2024 to Apr 18, 2024
    • Interventions: Lemborexant (Drug) to Lemborexant (Drug), Placebo (Drug)
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Trial Details
NCT Number NCT06262594
Lead Sponsor University of Manitoba
Collaborators: Duke University
Conditions
(from sponsor)		 Epilepsy, Sleep
Related terms Epilepsy
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov